Last Price
0.171
Today's Change
+0.061 (55.45%)
Day's Change
0.107 - 0.223
Trading Volume
662,400,696
Profile
AEON
Exchange: NASDAQ NASDAQ
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Marc Forth Mr. Marc Forth
Full Time Employees: 5 5
IPO Date: 2023-07-24 2023-07-24
CIK: 0001622667 0001622667
ISIN: US00791X1000 US00791X1000
CUSIP: 00775E102 00775E102
Beta: 0.40 0.40
Last Dividend: 0.00 0.00
Dcf Diff: 13.42 13.42
Dcf: -5.54 -5.54
Description
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
1
Will Coinbase refund My Money, iF Scammed?
2
Will Coinbase refund My Money, iF Scammed?
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
